28 Sep 2022 , 03:16 PM
The company will strengthen and explore its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metros, tier 2 and tier 3 cities. The centers will be equipped to offer specialized services in precision medicine, genetics, genomics, and molecular diagnostics, along with the routine investigations of biochemistry and serology, which are commonly used in routine diagnostics tests.
The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health, and cancer care.
Krsnaa Diagnostics is the largest service provider of radiology and diagnostics services under a single roof in India. Currently, the company is present in 16 states and 2 Union Territories of India with 2,000 plus locations.
Commenting on the initiative, Chief Operating Officer, Ravinder Sethi said, “Currently, we operate most of our centers through hospitals. This initiative is set to bolster and accelerate our footprint in India and improve healthcare access for patients.
With this launch, we are getting closer to the patients to ensure we are present in places where there is unmet needs of healthcare delivery. Krsnaa Diagnostics is one of the largest diagnostics player offering disruptive competitive prices to its customers.”
At around 3:15 PM, Krsnaa Diagnostics was trading at Rs488.65 per share higher by 1.15% on the BSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.